Literature DB >> 6744712

Nonconstrained total elbow arthroplasty.

G M Rosenberg, R H Turner.   

Abstract

Twenty-eight nonconstrained capitellocondylar elbow offhroplasties were performed in 23 patients. The clinical criteria were intractable pain in a joint with radiologic destruction from rheumatoid arthritis. Patients were examined at an average of 35 months postsurgery with the Ewald scoring system. Results were satisfactory in 24 elbows (86%) and unsatisfactory in four (14%). Pain relief and functional improvement were dramatic. The average arc of motion increased from 88 degrees preoperation to 101 degrees postoperation. There was an average 33 degrees residual flexion contracture. There was one failure from loosening, but no radiographic or clinical loosening was detected in the remaining patients. Postoperative dislocation was the most frequent complication, occurring in four cases. One dislocation required revision while three stabilized following four weeks of immobilization. There were two remote infections occurring two and five years postoperation. Although complications are frequent, this is a predictably successful procedure in properly selected patients.

Entities:  

Mesh:

Year:  1984        PMID: 6744712

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Radiographic study on the pattern of wrist joint destruction in rheumatoid arthritis.

Authors:  Takashi Kitamura; Tsuyoshi Murase; Jun Hashimoto; Tetsuya Tomita; Sayuri Arimitsu; Hideki Yoshikawa; Kazuomi Sugamoto
Journal:  Clin Rheumatol       Date:  2010-09-22       Impact factor: 2.980

2.  Radiographic study of joint destruction patterns in the rheumatoid elbow.

Authors:  Takashi Kitamura; Jun Hashimoto; Tsuyoshi Murase; Tetsuya Tomita; Takako Hattori; Hideki Yoshikawa; Kazuomi Sugamoto
Journal:  Clin Rheumatol       Date:  2006-05-03       Impact factor: 2.980

Review 3.  Systematic review of primary total elbow prostheses used for the rheumatoid elbow.

Authors:  J C T van der Lugt; P M Rozing
Journal:  Clin Rheumatol       Date:  2004-04-16       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.